AI Drug Discovery Platform

An AI drug discovery platform should do more than generate predictions. It should help a team make better decisions every week, reduce lab cycles, and improve the odds that a hit becomes a real lead. SandboxAQ's approach centers on physics-grounded quantitative AI, built into solutions like AQBioSim.

If you are evaluating platforms right now, the quickest way to cut through the noise is to focus on what actually changes outcomes: fidelity, workflow integration, speed, and learning loops.

What an AI drug discovery platform is supposed to replace

Most discovery teams already have a patchwork stack: screening tools, property predictors, modeling and simulation scripts, experiment tracking, and dashboards that do not connect to decisions.

The platform question is not "do we have AI?" It is:

• can we trust the signals enough to act on them
• can we move faster without increasing risk
• can we repeat the workflow across programs and targets

This is where AI drug discovery and AI drug simulation become platform requirements, not side experiments.

The non-negotiables: a buyer's checklist

1) Physics grounding and quantitative behavior

A platform that is purely pattern-based can look strong until it meets edge cases, sparse data, or new chemical space. Look for:

• physics-based simulation in the loop
• quantitative outputs that map to scientific reality
• uncertainty estimates that prevent false confidence

SandboxAQ's Large Quantitative Models are built around exactly this — scientific systems modeled with quantitative fidelity, not just correlations.

2) A workflow that matches how teams actually work

A platform fails when it forces teams into unnatural steps. You want:

• clear handoffs between comp chem, med chem, and biology
• a shared record of decisions, assumptions, and outcomes
• tight integration with assay results and iteration planning

If the output does not influence what gets synthesized or tested next, it is not integrated.

3) Speed that fits decision cycles

Even high-quality simulation is useless if it arrives late. Evaluate:

• time-to-answer for common questions
• ability to run enough candidates to support weekly or biweekly decisions
• scalability without turning into a queueing problem

A practical test: can the platform support triage and prioritization at the pace your program runs.

4) Signal you can explain, not just visualize

Explainability should help a scientist form a hypothesis. You should be able to answer:

• why compound A is ranked above compound B
• what modification is likely to improve the next property
• where the model is uncertain and why

If the platform cannot produce a usable rationale, adoption breaks when results get ambiguous.

5) Closed-loop learning that compounds

The best platforms treat every experiment as an opportunity to improve future decisions. Look for:

• outcomes flowing back into modeling and prioritization
• performance tracking by target, series, and assay type
• calibration that improves over time

This is where platforms separate themselves from toolkits.

Platform evaluation questions you can use in a demo

These questions tend to expose platform maturity fast:

1. Show me how you prioritize a batch from idea to shortlist.
2. Show me uncertainty on the ranking, not just point predictions.
3. Show me how assay results are incorporated and how the system improves.
4. Show me the workflow history so I can audit why a decision was made.
5. Show me how you scale from one target to a portfolio.

If you cannot get clear answers to these, you are buying a set of features, not a platform.

Where AQBioSim fits

If your goal is a production-grade AI drug discovery platform, AQBioSim is positioned around physics-based simulation plus quantitative AI, decision-grade outputs for discovery teams, and repeatable workflows that support iteration and learning. A platform should help teams converge faster, not just compute more.

Why chemical simulation matters even in drug discovery

Drug discovery does not live in isolation. Many teams share infrastructure and scientific talent across chemistry-heavy problems. If you need simulation capability that extends beyond life sciences workflows, AQChemSim supports broader chemistry simulation needs while keeping methods consistent across domains.

A simple scoring model for your shortlist

If you need to score vendors quickly, rate each on a 1–5 scale:

• Fidelity: is it grounded in physics or mostly statistical?
• Speed: does it fit your decision cadence?
• Workflow: does it match how your team operates?
• Explainability: can scientists use it to form hypotheses?
• Learning loop: does it improve with every experiment?

A platform that wins on all five tends to drive real cycle reduction.

If you are building or modernizing your stack:

• AQBioSim
• Large Quantitative Models
• AQChemSim
• SandboxAQ

‍